USA - engelsk - NLM (National Library of Medicine)

a-s medication solutions - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies - temporarily relieves sinus congestion and pressure

USA - engelsk - NLM (National Library of Medicine)

cardinal health 110, llc dba leader - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies - temporarily relieves sinus congestion and pressure

USA - engelsk - NLM (National Library of Medicine)

aurohealth llc - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - pseudoephedrine hydrochloride 120 mg - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies - temporarily relieves sinus congestion and pressure if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. - heart disease - high blood pressure - thyroid disease - diabetes - trouble urinating due to an enlarged prostate gland -  nervousness, dizziness, or sleeplessness occur - symptoms do not improve within 7 days or occur with a fever

Malta - engelsk - Medicines Authority

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - ephedrine hydrochloride - solution for injection - ephedrine hydrochloride 30 mg/ml - cardiac therapy

Irland - engelsk - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - ephedrine hydrochloride - solution for injection - 30 milligram(s)/millilitre - ephedrine

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chanelle medical - pseudoephedrine hydrochloride; paracetamol - tablet - 500/30 milligram(s) - anilides; paracetamol; sympathomimetics; pseudoephedrine

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

macarthys laboratories ltd (0000003530) bampton road, harold hill, romford, essex, rm3 8ug - ephedrine hydrochloride - solution for injection - 3% w/v - ephedrine hydrochloride (0000050986) 3% w/v - ephedrine

Israel - engelsk - Ministry of Health

raz pharmaceutics ltd, israel - ephedrine hydrochloride - solution for injection - ephedrine hydrochloride 50 mg / 1 ml - ephedrine - ephedrine hydrochloride is used in the prevention and treatment of hypotension from spinal or epidural anesthesia and during general anesthesia, with or without a reduction in the heart rate, administered for a surgical or obstetric procedure.

Malta - engelsk - Medicines Authority

glaxosmithkline consumer healthcare (ireland) limited 12, riverwalk, citywest business campus, dublin 24, ireland - ibuprofen, pseudoephedrine hydrochloride - coated tablet - ibuprofen 200 mg pseudoephedrine hydrochloride 30 mg - antiinflammatory and antirheumatic products

USA - engelsk - NLM (National Library of Medicine)

stat rx usa llc - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 180 mg - allegra-d 24 hour extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. allegra-d 24 hour should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). allegra-d 24 hour is contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, allegra-d 24 hour is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment (see drug interactions section). it is also contraindicated in patients with severe hypertension, or severe co